Metformine Sandoz

Metformin Hydrochloride, the active ingredient in Metformine Sandoz, is a biguanide presented as an oral tablet for oral use. It is employed to improve blood glucose control in adults with type 2 diabetes mellitus.

GNH USA supplies Metformine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. Our quality‑assured product meets EU standards and is available for global distribution. The product is manufactured under stringent GMP conditions and undergoes rigorous quality testing before release.

Metformine Sandoz, a biguanide antidiabetic, acts on the glucose metabolism pathway to lower elevated blood sugar in patients with type 2 diabetes mellitus, complementing lifestyle measures and other therapies.

Type 2 diabetes mellitus: improves overall glycemic control by decreasing hepatic glucose production, increasing peripheral insulin sensitivity, and reducing fasting and post‑prandial glucose excursions, thereby assisting patients in reaching individualized HbA1c targets. Combination therapy: may be used together with sulfonylureas, DPP‑4 inhibitors, SGLT2 inhibitors, or insulin to enhance glycemic control when monotherapy is insufficient.

Metformine Sandoz may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Abdominal discomfort - Metallic taste

Serious or Rare Side Effects: - Lactic acidosis - Severe hypoglycemia (especially when combined with insulin or sulfonylureas) - Vitamin B12 deficiency

When prescribing Metformine Sandoz, clinicians should consider several safety measures. - Renal function monitoring: assess eGFR before initiation and periodically during therapy. - Hepatic function assessment: evaluate liver enzymes as metformin is contraindicated in severe hepatic impairment. - Risk of lactic acidosis: avoid use in patients with conditions predisposing to hypoxia or metabolic acidosis. - Pregnancy and lactation: safety not established; prescribe only if potential benefit outweighs risk. - Elderly patients: start at lower dose and monitor for accumulation. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Metformine Sandoz interacts with several medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure; discontinue metformin before and after the procedure. - Alcohol intake: excessive consumption increases risk of lactic acidosis. - Cimetidine: can increase metformin plasma concentrations.

Moderate Interactions (Monitor Closely): - Sulfonylureas or insulin: combined use can increase risk of hypoglycemia. - Diuretics (especially thiazides): may affect renal clearance of metformin. - DPP‑4 inhibitors and SGLT2 inhibitors: require monitoring of glycemic response and renal function.